Current interest in HCV therapy with direct acting antivirals is focused on shortening treatment length. We managed two cirrhotics who achieved virological cure after 4 weeks of ombitasvir/paritaprevir/ritonavir, dasabuvir, ribavirin treatment. Analysis to identify potential predictive factors for a successful outcome with a shorter treatment course was conducted.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1080/1120009X.2017.1376782 | DOI Listing |
Publication Analysis
Top Keywords
shorter treatment
8
treatment course
8
course chronic
4
chronic hepatitis
4
hepatitis inspiring
4
inspiring cases
4
cases current
4
current interest
4
interest hcv
4
hcv therapy
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!